FGF23 and chronic kidney disease: Using bioengineered cardio-bundles, primary culture of NRVM, gain-of-function and loss-of function genetic mouse models, we further show that FGF23-mediated activation of FGFR4 is one potential underlying mechanism of cardiac mitochondrial dysfunction and metabolic remodeling in mice with CKD.